Stock IdeasStrong Buy Stocks

Strong Buy Stocks from Top Wall Street Analysts

Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Jefferies's Tycho Peterson raised their price target on Danaher (NYSE: DHR) by 3.9% from $255 to $265 on 2026/01/30. The analyst maintained their Strong Buy rating on the stock.

Danaher reported its Q4 and FY 2025 earnings.

According to Peterson, the earnings call was "relatively ordinary" in comparison to previous remarks.

The commentary was optimistic, and the order trends point to 2026 high-single-digit growth, the analyst added.

Looking ahead, Peterson opined that "the post-preint debate hinges on areas of upside, including bioprocessing equipment and life sciences, with the pathway and cadence key to the stock price moving higher.

A more constructive M&A backdrop also adds a potential catalyst, the analsyt added.

Earnings Report

Danaher reported:

For Q4 2025:

• EPS of $2.23, which beat the Zacks Consensus Estimate of $2.22 and, by 4%, Q4 2024’s $2.14.
• Revenue of $6.84B, which beat the Zacks Consensus Estimate by 0.64% and, by 4.5%, Q4 2024’s $6.54B.

For FY 2025:

• EPS of $7.80, up 4.5% Y/Y.
• Revenue of $24.6B, up 3.0% Y/Y.

Management guided:

For Q1 2026:

• Revenue growth in the low single-digit.

For FY 2026:

• EPS of $8.35 to $8.50.
• Revenue growth of 3% to 6%.

President & CEO Rainer M. Blair commented: "We delivered a strong finish to the year with better-than-expected performance across our portfolio.  

“We were particularly encouraged by continued strength in our bioprocessing business, along with improved momentum in Diagnostics and Life Sciences.  

“Our teams' disciplined execution also enabled us to exceed our fourth quarter margin, earnings, and cash flow expectations.

"Looking ahead, we expect the gradual improvement in our end markets we saw through 2025 to continue, and we believe the combination of our differentiated portfolio, the power of the Danaher Business System, and the strength of our balance sheet positions Danaher for long-term value creation as we move into 2026 and beyond."